Franklin Resources’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08M	Buy	113,878 +72,855	+178%	+$2.45M	﹤0.01%	1736
2025 Q4	$1.76M	Buy	41,023 +4,430	+12%	+$167K	﹤0.01%	1851
2025 Q3	$1.04M	Buy	36,593 +12,220	+50%	+$366K	﹤0.01%	2080
2025 Q2	$457K	Buy	24,373 +135	+0.6%	+$2.56K	﹤0.01%	2361
2025 Q1	$436K	Buy	24,238 +2,429	+11%	+$49.3K	﹤0.01%	2323
2024 Q4	$367K	Buy	21,809 +9,043	+71%	+$173K	﹤0.01%	2431
2024 Q3	$193K	Buy	+12,766	New	+$150K	﹤0.01%	2646
2024 Q2	–	Sell	-7,006	Closed	-$104K	–	2955
2024 Q1	$104K	Hold	7,006	–	–	﹤0.01%	2706
2023 Q4	$102K	Hold	7,006	–	–	﹤0.01%	2468
2023 Q3	$75.7K	Sell	7,006 -11,062	-61%	-$133K	﹤0.01%	2488
2023 Q2	$233K	Buy	18,068 +12,373	+217%	+$167K	﹤0.01%	2314
2023 Q1	$75.2K	Sell	5,695 -379	-6%	-$6.02K	﹤0.01%	2145
2022 Q4	$91.1K	Buy	6,074 +169	+3%	+$1.55K	﹤0.01%	2139
2022 Q3	$69K	Buy	5,905 +54	+0.9%	+$730	﹤0.01%	2163
2022 Q2	$66K	Sell	5,851 -2,734	-32%	-$54.9K	﹤0.01%	2208
2022 Q1	$257K	Buy	8,585 +419	+5%	+$11.3K	﹤0.01%	2077
2021 Q4	$216K	Buy	8,166 +6,768	+484%	+$204K	﹤0.01%	2209
2021 Q3	$50K	Buy	1,398 +150	+12%	+$5.9K	﹤0.01%	2379
2021 Q2	$54K	Buy	+1,248	New	+$47.1K	﹤0.01%	1951